Trial intelligence / Profile preview

Atosiban vs. Nifedipine for Preterm Labor in Twin Pregnancy

NCT02725736Phase 3Unknown

Sponsor
Tel Aviv Sourasky Medical Center
Start
Mar 2016
Primary completion
Mar 2018
Modality
Peptides, Small Molecules
01

Overview

Phase 3, randomised, open-label trial of atosiban in Preterm labor (PTL) (2 arms), sponsored by Tel Aviv Sourasky Medical Center. Primary endpoint: Duration of labor at 48 hours. Status: unknown.

02

Drugs

atosiban
03

Conditions

Preterm labor (PTL)

Beyond the preview

Go deeper on NCT02725736.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02725736.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call